These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Large animal models contribute to the development of therapies for central and peripheral nervous system dysfunction in patients with lysosomal storage diseases. Gurda BL; Vite CH Hum Mol Genet; 2019 Oct; 28(R1):R119-R131. PubMed ID: 31384936 [TBL] [Abstract][Full Text] [Related]
28. Gene therapy for the lysosomal storage disorders. Cabrera-Salazar MA; Novelli E; Barranger JA Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873 [TBL] [Abstract][Full Text] [Related]
29. Gene therapy for lysosomal storage diseases and peroxisomal diseases. Ohashi T J Hum Genet; 2019 Feb; 64(2):139-143. PubMed ID: 30498239 [TBL] [Abstract][Full Text] [Related]
30. Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases. Siddiqi F; Wolfe JH Hum Gene Ther; 2016 Oct; 27(10):749-757. PubMed ID: 27420186 [TBL] [Abstract][Full Text] [Related]
31. Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts? Hawkins-Salsbury JA; Reddy AS; Sands MS Hum Mol Genet; 2011 Apr; 20(R1):R54-60. PubMed ID: 21421999 [TBL] [Abstract][Full Text] [Related]
32. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications. Biffi A Mol Ther; 2017 May; 25(5):1155-1162. PubMed ID: 28389320 [TBL] [Abstract][Full Text] [Related]
33. An update on gene therapy for lysosomal storage disorders. Nagree MS; Scalia S; McKillop WM; Medin JA Expert Opin Biol Ther; 2019 Jul; 19(7):655-670. PubMed ID: 31056978 [TBL] [Abstract][Full Text] [Related]
34. Gene transfer strategies for correction of lysosomal storage disorders. D'Azzo A Acta Haematol; 2003; 110(2-3):71-85. PubMed ID: 14583667 [TBL] [Abstract][Full Text] [Related]
36. Immune system irregularities in lysosomal storage disorders. Castaneda JA; Lim MJ; Cooper JD; Pearce DA Acta Neuropathol; 2008 Feb; 115(2):159-74. PubMed ID: 17924126 [TBL] [Abstract][Full Text] [Related]
37. Gene therapy of lysosomal storage disorders. Salvetti A; Heard JM; Danos O Br Med Bull; 1995 Jan; 51(1):106-22. PubMed ID: 7767637 [TBL] [Abstract][Full Text] [Related]
38. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases. Li M Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286 [TBL] [Abstract][Full Text] [Related]
39. Treatment options for lysosomal storage disorders: developing insights. van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070 [TBL] [Abstract][Full Text] [Related]
40. Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models. Brooks DA Mol Genet Metab; 1999 Oct; 68(2):268-75. PubMed ID: 10527678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]